Stryker announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), which is developing a next-genera ...

Artivion plans to acquire Endospan for $135 miillion, net of previously extended loans. Endospan’s Nexus aortic arch stent graft recently received FDA approval. Artivion has long supported Endospan’s ...

Rapid Medical announced full results from the DISTALS randomized clinical trial demonstrating that the company’s Tigertriever ...

Teleflex Incorporated announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8 ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...

In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common ...

Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon ...

Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...

A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...

April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...